Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect?

Journal of Clinical Investigation

Volumn 114, Issue 1, 2004, Pages 23-27

  Dickson, Dennis W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE; CYTOSKELETON PROTEIN; NUCLEAR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; DEGENERATIVE DISEASE; DEMENTIA; ENZYME ACTIVATION; HUMAN; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; BIOLOGICAL MODEL; GENETICS; MOLECULAR BIOLOGY; NOTE; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOPTOSIS; HUMANS; MODELS, NEUROLOGICAL; MOLECULAR BIOLOGY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES;

EID: 85047693458     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22317     Document Type: Review

References (28)

1. Dickson, D.W. 1997. Pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:321-339.
2. Grundke-Iqbal, I., et al. 1986. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261:6084-6089.
3. Tanzi, R.E., and Bertram, L. 2001. New frontiers in Alzheimer's disease genetics. Neuron. 32:181-184.
4. Grober, E., et al. 1999. Memory and mental status correlates of modified Braak staging. Neurobiol. Aging. 20:573-579.
5. Bennett, D.A., Schneider, J.A., Wilson, R.S., Bienias, J.L., and Arnold, S.E. 2004. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol. 61:378-384.
6. Mandelkow, E.M., Stamer, K., Vogel, R., Thies, E., and Mandelkow, E. 2003. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol. Aging. 24:1079-1085.
7. Golde, T.E. 2003. Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest. 111:11-18. doi:10.1172/JCI200317527.
8. Rissman, R.A., et al. 2004. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest. 114:121-130. doi:10.1172/JCI200420640.
9. Cotman, C.W., and Anderson, A.J. 1995. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:19-45.
10. Stadelmann, C., Bruck, W., Bancher, C., Jellinger, K., and Lassmann, H. 1998. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J. Neuropathol. Exp. Neurol. 57:456-464.
11. Migheli, A., Cavalla, P., Marino, S., and Schiffer, D. 1994. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53:606-616.
12. Schultz, D.R., and Harrington, W.J., Jr. 2003. Apoptosis: programmed cell death at a molecular level. Semin. Arthritis Rheum. 32:345-369.
13. Su, J.H., Zhao, M., Anderson, A.J., Srinivasan, A., and Cotman, C.W. 2001. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res. 898:350-357.
14. Mattson, M.P., Keller, J.N., and Begley, J.G. 1998. Evidence for synaptic apoptosis. Exp. Neurol. 153:35-48.
15. Gong, Y., et al. 2003. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U. S. A. 100:10417-10422.
16. Glabe, C. 2001. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17:137-145.
17. Oddo, S., et al. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 39:409-421.
18. Lustbader, J.W., et al. 2004. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science. 304:448-452.
19. Gamblin, T.C., et al. 2003. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 100:10032-10037.
20. Yen, S.H, Hutton, M., DeTure, M., Ko, L.W., and Nacharaju, P. 1999. Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17. Brain Pathol. 9:695-705.
21. Weaver, C.L., Espinoza, M., Kress, Y., and Davies, P. 2000. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging. 21:719-727.
22. Jicha, G.A., Bowser, R., Kazam, I.G., and Davies, P. 1997. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48:128-132.
23. Jicha, G.A., O'Donnell, A., Weaver, C., Angeletti, R., and Davies, P. 1999. Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase. J. Neurochem. 72:214-224.
24. Wischik, C.M., et al. 1988. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 85:4506-4510.
25. Canu, N., et al. 1998. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18:7061-7074.
26. Johnson, G.V., Jope, R.S., and Binder, L.I. 1989. Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163:1505-1511.
27. Wang, K.K. 2000. Calpain and caspase: can you tell the difference? Trends Neurosci. 23:20-26.
28. Lee, M.K., et al. 2002. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99:8968-8973.